Development and validation of a risk model for effective immune and stromal related signature predicting prognosis of patients with ovarian cancer

Abstract The tumor microenvironment (TME) plays a critical role in ovarian cancer (OC) progression, yet the relationship between immune and stromal scores within the TME and prognostic outcomes remains poorly understood. Immune and stromal cell scores were computed using the “estimate” R package, wh...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Yiping Yu, Wen Yin, Jing Feng, Sumin Qian
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-05-01
Subjects:	Ovarian cancer ESTIMATE GSEA Prognostic signature Immune drug response
Online Access:	https://doi.org/10.1038/s41598-025-01212-x

Similar Items

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
by: Yinan Hu, et al.
Published: (2022-02-01)

Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer
by: Li-Hong Wu, et al.
Published: (2023-03-01)

A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
by: Linhua Zhu, et al.
Published: (2024-03-01)

Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer
by: Jiani Yang, et al.
Published: (2024-02-01)

A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-09-01)

Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients
by: Xiaoqing Guan, et al.
Published: (2021-02-01)

A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-04-01)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
by: He Li, et al.
Published: (2022-10-01)

The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma
by: Fangshi Xu, et al.
Published: (2020-12-01)

Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
by: Liang Lin, et al.
Published: (2022-06-01)

Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis
by: Peng Xing, et al.
Published: (2022-08-01)

Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma
by: Xuan Wang, et al.
Published: (2024-07-01)

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors
by: Dong Yang, et al.
Published: (2023-09-01)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
by: Rongjia Su, et al.
Published: (2022-05-01)

Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG)
by: Kunjian Lei, et al.
Published: (2024-03-01)

Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment
by: Jianlei Bi, et al.
Published: (2021-09-01)

A cuproptosis-related signature predicts prognosis and indicates cross-talk with immunocyte in ovarian cancer
by: Bikang Yang, et al.
Published: (2024-05-01)

Development and validation of an immune‐related gene signature for prognosis in Lung adenocarcinoma
by: Zehuai Guo, et al.
Published: (2023-02-01)

A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning
by: Bo Zhao, et al.
Published: (2023-10-01)

A prognostic signature based on three non‐coding RNAs for prediction of the overall survival of glioma patients
by: Junmin Xian, et al.
Published: (2019-04-01)

Machine learning developed a CD8+ exhausted T cells signature for predicting prognosis, immune infiltration and drug sensitivity in ovarian cancer
by: Rujun Chen, et al.
Published: (2024-03-01)

Identification and validation of an m7G-related lncRNAs signature for predicting prognosis, immune response and therapy landscapes in ovarian cancer
by: Jixin Li, et al.
Published: (2024-10-01)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
by: Zeyu Zhang, et al.
Published: (2022-01-01)

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer
by: Zitao Wang, et al.
Published: (2022-06-01)

Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma
by: Yu-Hang Ye, et al.
Published: (2024-10-01)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
by: Yang Chen, et al.
Published: (2023-04-01)

Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target
by: Yixin Zhang, et al.
Published: (2023-01-01)

Novel immune-related prognostic model and nomogram for breast cancer based on ssGSEA
by: Linrong Li, et al.
Published: (2023-01-01)

A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma
by: Yang Zhou, et al.
Published: (2022-03-01)

Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer
by: Zhe Cheng, et al.
Published: (2023-01-01)

Identification of STEAP3-based molecular subtype and risk model in ovarian cancer
by: Zouyu Zhao, et al.
Published: (2023-06-01)

A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer
by: Yiqi Duan, et al.
Published: (2023-06-01)

Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System
by: Tingshan He, et al.
Published: (2021-05-01)

An anoikis-related gene signature predicts prognosis, drug sensitivity, and immune microenvironment in cholangiocarcinoma
by: Guochao Liu, et al.
Published: (2024-06-01)

A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers
by: Qixuan Li, et al.
Published: (2024-05-01)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
by: Huihan Yu, et al.
Published: (2022-08-01)

Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-10-01)

Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer
by: Yuling Qin, et al.
Published: (2024-05-01)

Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
by: Yu-Hang Ye, et al.
Published: (2025-01-01)

Decoding the Ferroptosis-Related Gene Signatures and Immune Infiltration Patterns in Ovarian Cancer: Bioinformatic Prediction Integrated with Experimental Validation
by: Zhang B, et al.
Published: (2024-12-01)